Prostatic Artery Embolization vs. Pharmacotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: a Multicenter Randomized Controlled Trial (EMPATHY)

NCT04245566 Phase 3 UNKNOWN

This study compares safety and efficacy of prostatic artery embolization and pharmacotherapy in the treatment of lower urinary tract symptoms associated wit benign prostatic hyperplasia.

Details

Lead sponsor	Dominik Abt
Phase	Phase 3
Status	UNKNOWN
Enrolment	425
Start date	2021-09
Completion	2025-12

Conditions

• Benign Prostatic Hyperplasia
• Pharmacotherapy
• Prostatic Artery Embolization
• Minimally Invasive Treatment

Interventions

• Prostatic Artery Embolization (PAE)
• Pharmacotherapy

Primary outcomes

• International Prostate Symptoms Score (IPSS) — 24 months after treatment initiation
  The International Prostate Symptoms Score (IPSS) measures the degree of symptoms associated with benign prostatic hyperplasia (BPH). Range of values 0-35 points. Higher values indicate more severe symptoms.